Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 35792273)

  • 1. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
    Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
    Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 3. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Shi Y; Sang X; Deng J; Wang Y; Chen X; Lin S; Wu F; Xu A
    J Cancer; 2023; 14(1):9-23. PubMed ID: 36605491
    [No Abstract]   [Full Text] [Related]  

  • 6. Progesterone receptor gene serves as a prognostic biomarker associated with immune infiltration in gastric cancer: a bioinformatics analysis.
    Li M; Zhou C
    Transl Cancer Res; 2021 Jun; 10(6):2663-2677. PubMed ID: 35116579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer.
    Cui G; Geng L; Zhu L; Lin Z; Liu X; Miao Z; Jiang J; Feng X; Wei F
    J Cancer; 2021; 12(11):3378-3390. PubMed ID: 33976747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer.
    Bao D; Zhang C; Li L; Wang H; Li Q; Ni L; Lin Y; Huang R; Yang Z; Zhang Y; Hu Y
    Front Oncol; 2020; 10():553297. PubMed ID: 33614473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers.
    Liu X; Xu Q; Li Z; Xiong B
    Sci Rep; 2020 Nov; 10(1):20795. PubMed ID: 33247170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
    Liang Z; Li X
    Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of prostaglandin I2 synthase and its correlation with tumor-infiltrating immune cells in lung cancer, ovarian cancer, and gastric cancer.
    Dai D; Chen B; Feng Y; Wang W; Jiang Y; Huang H; Liu J
    Aging (Albany NY); 2020 May; 12(10):9658-9685. PubMed ID: 32463792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CALD1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers.
    Liu Y; Xie S; Zhu K; Guan X; Guo L; Lu R
    Heliyon; 2021 Jun; 7(6):e07257. PubMed ID: 34189308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
    Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
    Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and immunological role of Fam20C in pan-cancer.
    Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD.
    Wang Z; Tian Z; Song X; Zhang J
    BMC Immunol; 2022 Jan; 23(1):1. PubMed ID: 34998385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Hou W; Kong L; Hou Z; Ji H
    BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BOLA3 is a prognostic-related biomarker and correlated with immune infiltrates in lung adenocarcinoma.
    Wang XF; Lei W; Liu CM; Yang J; Zhu YH
    Int Immunopharmacol; 2022 Jun; 107():108652. PubMed ID: 35286914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.